Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tendoncel for Lateral Epicondylitis
NCT03811145Phase 2Completed
- Start
- May 2014
- Primary completion
- Nov 2015
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Lateral Epicondylitis (LET) comparing Tendoncel with Placebo (2 arms). Primary endpoints: Patient-Rated Tennis Elbow Evaluation at 47 weeks, Disabilities of the Arm, Shoulder and Hand at 47 weeks and 1 more. Started May 2014; status: completed.
02
Drugs
Tendoncel
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT03811145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03811145.